Supplementary Material from <i>In silico</i> simulation of a clinical trial with anti-CTLA-4 and anti-PD-L1 immunotherapies in metastatic breast cancer using a systems pharmacology model.

Name: Supplementary Material from In silico simulation of a clinical trial with anti-CTLA-4 and anti-PD-L1 immunotherapies in metastatic breast cancer using a systems pharmacology model.
Creator: Bartelink, Imke H.; Wang, Bing; Vicini, Paolo; Santa-Maria, Cesar A.; Narwal, Rajesh; Wang, Hanwen; S. Popel, Aleksander; Roskos, Lorin; Milberg, Oleg
Published: 2020-10-15T00:00:00+08:00